Join to View Full Profile
11937 Us Highway 271Tyler, TX 75708
Phone+1 903-877-7777
Fax+1 903-877-5838
Are you Dr. Idell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Idell, MD is a pulmonologist in Tyler, Texas. He is currently licensed to practice medicine in Texas.
Education & Training
Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1983- Temple University HospitalResidency, Internal Medicine, 1977 - 1980
Lewis Katz School of Medicine at Temple UniversityClass of 1977
Certifications & Licensure
TX State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- The Role of Tuftelin-1 in Mesomesenchymal Transition of Pleural Mesothelial Cells and the Progression of Pleural Fibrosis.Ann Jeffers, Shuzi Owens, Wenyi Qin, Olamipejo Durojaye, Matt Florence
American Journal of Respiratory Cell and Molecular Biology. 2025-02-25 - Intrapleural Fibrinolytic Interventions for Retained Hemothoraces in Rabbits.Christian J De Vera, Jincy Jacob, Krishna Sarva, Sunil Christudas, Rebekah L Emerine
International Journal of Molecular Sciences. 2024-08-12 - 1 citationsMyocardin regulates fibronectin expression and secretion from human pleural mesothelial cells.Tsuyoshi Sakai, Young-Yeon Choo, Shinya Mitsuhashi, Reiko Ikebe, Ann Jeffers
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2024-04-01
Press Mentions
Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19September 9th, 2020
East Texas Researchers Studying More Effective Treatments for Cancer, Other Incurable DiseasesJanuary 30th, 2020- UTHSC: $1.4 Million Grant Renewal to Inspire Tuberculosis Research at Tyler Research CenterNovember 5th, 2019
- Join now to see all
Grant Support
- Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyemaUNIVERSITY OF TEXAS HLTH CTR AT TYLER2017–2025
